Quality-of-life comparisons in a randomized trial of interval secondary cytoreduction in advanced ovarian carcinoma: a Gynecologic Oncology Group study.

Source:http://linkedlifedata.com/resource/pubmed/id/16110020

J. Clin. Oncol. 2005 Aug 20 23 24 5605-12

Download in:

View as

Triples

General Info

PMID
16110020